Search Results - "Bae, You Han"

Refine Results
  1. 1

    In Vivo Evaluation of Doxorubicin-Loaded Polymeric Micelles Targeting Folate Receptors and Early Endosomal pH in Drug-Resistant Ovarian Cancer by Kim, Dongin, Gao, Zhong Gao, Lee, Eun Seong, Bae, You Han

    Published in Molecular pharmaceutics (05-10-2009)
    “…The second generation of pH-sensitive micelles composed of poly(l-histidine-co-l-phenlyalanine(16 mol %))(MW:5K)-b-PEG(MW:2K) and poly(l-lactic…”
    Get full text
    Journal Article
  2. 2

    Doxorubicin Loaded pH-sensitive Micelle: Antitumoral Efficacy against Ovarian A2780/DOXR Tumor by Kim, Dongin, Lee, Eun Seong, Park, Kyeongsoon, Kwon, Ick Chan, Bae, You Han

    Published in Pharmaceutical research (01-09-2008)
    “…Purpose To evaluate pH-sensitive mixed micelles for multidrug resistant (MDR) ovarian tumor targeting and optical imaging of solid tumors. Method Doxorubicin…”
    Get full text
    Journal Article
  3. 3

    Perspectives on the past, present, and future of cancer nanomedicine by Youn, Yu Seok, Bae, You Han

    Published in Advanced drug delivery reviews (01-05-2018)
    “…The justification of cancer nanomedicine relies on enhanced permeation (EP) and retention (R) effect and the capability of intracellular targeting due…”
    Get full text
    Journal Article
  4. 4

    Self-Organized Nanogels Responding to Tumor Extracellular pH:  pH-Dependent Drug Release and in Vitro Cytotoxicity against MCF-7 Cells by Na, Kun, Lee, Eun Seong, Bae, You Han

    Published in Bioconjugate chemistry (01-09-2007)
    “…The principal objective of this study was to fabricate doxorubicin-loaded self-organized nanogels composed of hydrophobized pullulan (PUL)-N α-Boc-l-histidine…”
    Get full text
    Journal Article
  5. 5

    Thermosensitive sol–gel reversible hydrogels by Jeong, Byeongmoon, Kim, Sung Wan, Bae, You Han

    Published in Advanced drug delivery reviews (01-12-2012)
    “…Aqueous polymer solutions that are transformed into gels by changes in environmental conditions, such as temperature and pH, thus resulting in in situ hydrogel…”
    Get full text
    Journal Article
  6. 6

    Odyssey of a cancer nanoparticle: From injection site to site of action by Nichols, Joseph W., Bae, You Han

    Published in Nano today (01-12-2012)
    “…[Display omitted] ► No drug can be effective against cancer until it is successfully delivered from the administration site to its site of action within the…”
    Get full text
    Journal Article
  7. 7

    The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives by Sun, Rui, Xiang, Jiajia, Zhou, Quan, Piao, Ying, Tang, Jianbin, Shao, Shiqun, Zhou, Zhuxian, Bae, You Han, Shen, Youqing

    Published in Advanced drug delivery reviews (01-12-2022)
    “…[Display omitted] Over the past three decades, the enhanced permeability and retention (EPR) effect has been considered the basis of tumor-targeted drug…”
    Get full text
    Journal Article
  8. 8

    Recent progress in tumor pH targeting nanotechnology by Lee, Eun Seong, Gao, Zhonggao, Bae, You Han

    Published in Journal of controlled release (18-12-2008)
    “…pH-sensitive polymeric micelles and nanogels have recently been developed to target slightly acidic extracellular pH environment of solid tumors. The pH…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Lipid raft-mediated and upregulated coordination pathways assist transport of glycocholic acid-modified nanoparticle in a human breast cancer cell line of SK-BR-3 by Deng, Feiyang, Han Bae, You

    Published in International journal of pharmaceutics (05-04-2022)
    “…[Display omitted] Bile acid transporter-targeting has been proven to be an effective strategy to improve drug delivery to hepatocytes and enterocytes. With…”
    Get full text
    Journal Article
  10. 10

    Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model by Suzuki, Kenichi, Kim, Kyoung Sub, Bae, You Han

    Published in Journal of controlled release (28-01-2019)
    “…Exendin-4 is a glucagon-like peptide-1 (GLP-1) receptor agonist and potent insulinotropic agent for type 2 diabetes patients; however, its therapeutic utility…”
    Get full text
    Journal Article
  11. 11

    Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: Characterization, aggregation, and adriamycin release in vitro by Na, Kun, Bae, You Han

    Published in Pharmaceutical research (01-05-2002)
    “…To investigate some physicochemical properties of self-assembled hydrogel nanoparticles of pullulan acetate (PA) and sulfonamide conjugates, as a potential…”
    Get full text
    Journal Article
  12. 12

    Stability of bovine serum albumin complexed with PEG-poly( l-histidine) diblock copolymer in PLGA microspheres by Kim, Jong-Ho, Taluja, Ajay, Knutson, Kristine, Han Bae, You

    Published in Journal of controlled release (05-12-2005)
    “…The aim of this study was to examine the stability of bovine serum albumin (BSA) in poly( dl-lactic acid- co-glycolic acid) (PLGA) microspheres upon addition…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Immune-triggered cancer treatment by intestinal lymphatic delivery of docetaxel-loaded nanoparticle by Kim, Kyoung Sub, Youn, Yu Seok, Bae, You Han

    Published in Journal of controlled release (01-10-2019)
    “…The maximally tolerated dose (MTD) approach in conventional chemotherapy accompanies adverse effects, primarily due to high drug concentrations in the blood…”
    Get full text
    Journal Article
  14. 14

    Role of a Novel Excipient Poly(ethylene glycol)-b-poly(l-histidine) in Retention of Physical Stability of Insulin at Aqueous/Organic Interface by Taluja, Ajay, Bae, You Han

    Published in Molecular pharmaceutics (01-07-2007)
    “…The aim of this study was to investigate whether a cationic polyelectrolyte, poly(ethylene glycol)-b-poly(l-histidine) diblock copolymer (PEG-polyHis), can…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling by Nichols, Joseph W., Sakurai, Yu, Harashima, Hideyoshi, Bae, You Han

    Published in Journal of controlled release (10-12-2017)
    “…Navigating intratumoral drug distribution has proven to be one of the most challenging aspects of drug delivery. The barriers are significant and varied;…”
    Get full text
    Journal Article
  18. 18

    Tumor heterogeneity and its implication for drug delivery by Denison, Tracy A., Bae, You Han

    Published in Journal of controlled release (10-12-2012)
    “…Evidence continues to accumulate that patient tumors contain heterogeneous cell populations, each of which may contribute differently in extent and mechanism…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Ovalbumin and Poly(i:c) Encapsulated Dendritic Cell‐Targeted Nanoparticles for Immune Activation in the Small Intestinal Lymphatic System by Kim, Kyoung Sub, Lee, Sanghee, Na, Kun, Bae, You Han

    Published in Advanced healthcare materials (01-11-2022)
    “…Here, antigen and adjuvant encapsulated dendritic cell‐targeted nanoparticles for immune activation in the small intestinal lymphatic system to inhibit…”
    Get full text
    Journal Article
  20. 20

    TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors by Sethuraman, Vijay A., Bae, You Han

    Published in Journal of controlled release (02-04-2007)
    “…A novel drug targeting system for acidic solid tumors has been developed based on ultra pH-sensitive polymer and cell penetrating TAT. The delivery system…”
    Get full text
    Journal Article